CAMBRIDGE, Mass. (AP) _ Genocea Biosciences Inc. (GNCA) on Thursday reported a loss of $7.8 million in its third quarter.
The Cambridge, Massachusetts-based company said it had a loss of 9 cents per share.
The results topped Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 10 cents per share.
The company's shares closed at 63 cents. A year ago, they were trading at $1.16.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on GNCA at https://www.zacks.com/ap/GNCA